Views & Analysis Why pharma needs to care about global warming Barely a day goes by without global warming or climate change (now more appropriately termed “climate crisis” by some media outlets) being in the news.
News Regeneron swoops on genetic testing firm 23andMe DNA testing company 23andMe looks destined to be taken over by a pharma company, as Regeneron agrees a $256 million acquisition deal.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.